Nathan E Botts / Wednesday, March 23, 2022 / Categories: Mental Health Innovation Speaker Series: Beyond FDA Approval: Assessing the Value of New Health Technologies Innovation Speaker Series: Beyond FDA Approval: Assessing the Value of New Health TechnologiesThe National Institute of Mental Health (NIMH) established the Director’s Innovation Speaker Series to encourage broad, interdisciplinary thinking in the development of scientific initiatives and programs, and to press for theoretical leaps in science over the continuation of incremental thought. On March 8, 2022, Foluso Agboola, MBBS, MPH provided a brief background on the Institute for Clinical and Economic Review (ICER) and describe the Value Assessment Framework (i.e., the conceptual framework and set of associated methods that guide the development of ICER’s evidence reports) using their review of esketamine for treatment-resistant depression as an example. Dr. Agboola will also provided examples of how ICER’s work is applied in the real world. Dr. Agboola is the Vice President of Research at ICER. This independent non-profit research institute generates evidence on the effectiveness and value of drugs and other medical services.Link to original article Previous Article Riya Dange, Winner of the 2020 Three-Minute Talks Competition Next Article NIMH Data Archive (NDA) New Grantee Orientation Webinar Print 95 Rate this article: No rating 0Upvote 0Downvote Leave a comment Name: Please enter a name. Email: Please enter an email address. Please enter a valid email address. Comment: Please enter comment. Add comment